Healthcare Global December 23, 2021
Helen Adams

Stephen Hoelper, Doceree President, North America, has some expectations for 2022 – here’s five ways he thinks tech will impact the Life Sciences Industry

Stephen Hoelper is President, North America of Doceree, the first global network of HCP-only platforms for programmatic messaging. Doceree is aiming to address the acute problem of rising cost of healthcare by bringing in efficiency and effectiveness in messaging to healthcare professionals by life sciences brands on digital platforms with methodical use of data and creativity.

Stephen has experience throughout his career conceptualising and realising healthcare go-to market strategies for start-ups and Fortune 50 companies.

Here, he shares with Healthcare, his predictions for 2022.

The landscape of the life sciences industry has transformed during the pandemic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Digital Health, FDA, Govt Agencies, Metaverse/VR, Pharma / Biotech, Technology, Telehealth, Voice Assistant, Wearables
Related Articles:
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
The Fed's Warnings On Inflation Are Bad News For Biotech Startups
AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More
Beyond National Health Expenditure Data: Three Things I Wish Were Better Measured

Share This Article